Estimation of Acid Phosphatase

Introduction

• Acid phosphatase (ACP) is an important hydrolytic enzyme that belongs to the group of phosphomonoesterases.

• It catalyzes the hydrolysis of phosphate esters in an acidic medium, usually at an optimal pH of around 4.5–5.5.

• The enzyme is widely distributed in many tissues of the human body including the prostate gland, liver, spleen, kidney, erythrocytes, platelets, and bone marrow.

• Among these tissues, the prostate gland contains the highest concentration of acid phosphatase, which makes the enzyme clinically significant in prostate-related disorders.

• Acid phosphatase is released into the bloodstream when tissues containing the enzyme are damaged or diseased.

• Measurement of serum acid phosphatase activity is therefore used as a biochemical marker for certain pathological conditions.

• Historically, the acid phosphatase test was widely used for the diagnosis and monitoring of carcinoma of the prostate before the development of prostate-specific antigen (PSA).

• Although PSA testing is now more common, acid phosphatase estimation still has diagnostic importance in specific clinical and laboratory settings.

• Acid phosphatase exists in multiple isoenzyme forms, including prostatic, erythrocytic, lysosomal, and osteoclastic acid phosphatases.

• Determination of acid phosphatase activity helps in the evaluation of bone diseases, prostate disorders, and certain hematological conditions.

Principle

• The acid phosphatase test is based on the enzymatic hydrolysis of a phosphate ester substrate in an acidic environment.

• In most laboratory methods, the substrate used is p-nitrophenyl phosphate (pNPP).

• Acid phosphatase catalyzes the hydrolysis of p-nitrophenyl phosphate into p-nitrophenol and phosphate ions.

• The reaction occurs optimally at an acidic pH, usually maintained using a citrate or acetate buffer.

• The liberated p-nitrophenol is colorless in acidic conditions but turns yellow in alkaline medium.

• After the enzymatic reaction, an alkaline solution is added to stop the reaction and develop the yellow color.

• The intensity of the yellow color formed is directly proportional to the activity of acid phosphatase present in the sample.

• The absorbance of the colored compound is measured spectrophotometrically at a wavelength of approximately 405 nm.

• The measured absorbance is compared with a standard or calibration factor to determine enzyme activity.

• The final result is expressed in International Units per liter (IU/L) of serum.

Method

• The most commonly used laboratory technique for acid phosphatase estimation is the kinetic spectrophotometric method.

• In this method, the enzyme activity is measured continuously by monitoring the rate of color formation.

• The substrate p-nitrophenyl phosphate is used because it provides a stable and reliable reaction.

• The reaction mixture contains buffer, substrate, and the serum sample containing acid phosphatase.

• The reaction is carried out at a controlled temperature, usually 37°C, to simulate physiological conditions.

• After incubation, the rate of formation of p-nitrophenol is measured spectrophotometrically.

• Some methods include tartrate inhibition to differentiate prostatic acid phosphatase from other isoenzymes.

• Tartrate-sensitive acid phosphatase represents the prostatic fraction of the enzyme.

Sample

• The preferred specimen for acid phosphatase estimation is serum obtained from venous blood.

• Blood should be collected using standard aseptic techniques.

• Hemolysis must be avoided because red blood cells contain acid phosphatase and can falsely elevate results.

• After blood collection, the sample should be allowed to clot and then centrifuged to separate serum.

• The serum should be analyzed as soon as possible after collection.

• Acid phosphatase is unstable at room temperature and may lose activity rapidly.

• If immediate analysis is not possible, the serum should be refrigerated at 2–8°C.

• In some cases, acidification of serum with acetate buffer may be done to stabilize the enzyme.

• Plasma samples are generally not preferred due to interference from anticoagulants.

• Proper sample handling is essential to obtain accurate and reliable results.

Requirements

• Spectrophotometer /colorimeter capable of measuring absorbance at 405 nm.

• Water bath or incubator maintained at 37°C.

• Test tubes or cuvettes suitable for spectrophotometric analysis.

• Micropipettes or calibrated pipettes for accurate measurement of reagents.

• Buffer solution to maintain acidic pH (usually acetate or citrate buffer).

• Substrate solution containing p-nitrophenyl phosphate.

• Stop solution or alkaline reagent such as sodium hydroxide.

• Distilled or deionized water.

• Standard enzyme solution or calibration standard.

• Timer, test tube rack, and laboratory safety equipment.

Procedure

• Label test tubes for blank, standard, and test samples.

• Add the required volume of buffer solution to each test tube.

• Add the p-nitrophenyl phosphate substrate solution to the tubes.

• Pre-incubate the reaction mixture at 37°C for a few minutes to equilibrate temperature.

• Add the serum sample to the test tube containing the reaction mixture.

• Mix gently to ensure proper mixing of reagents.

• Incubate the mixture at 37°C for a specified period, usually about 5–10 minutes.

• After incubation, add the alkaline stop solution to terminate the enzymatic reaction.

• The yellow color produced due to p-nitrophenol formation is measured at 405 nm using a spectrophotometer.

• Record the absorbance values for the test and standard solutions.

Calculation

• The activity of acid phosphatase is determined by comparing the absorbance of the test sample with the standard.

• A calibration factor may be used depending on the kit or method employed.

• The general formula used is:

  Acid Phosphatase Activity (IU/L) = Absorbance of Test × Factor

• The factor is provided by the reagent manufacturer or determined from the standard curve.

• In some methods, enzyme activity is calculated using the difference in absorbance per minute.

• The change in absorbance reflects the rate of enzyme activity.

• Higher absorbance values indicate greater enzyme activity in the sample.

• Results are usually reported in International Units per liter (IU/L).

• Normal reference ranges vary depending on the laboratory and method used.

• Proper calibration and quality control are essential for accurate calculations.

Clinical Significance

Increased Acid Phosphatase Levels

1. Carcinoma of the Prostate

   • Markedly elevated serum acid phosphatase levels are commonly associated with carcinoma of the prostate.

   • The increase is more significant when the cancer has metastasized to bone.

   • Prostatic acid phosphatase (PAP) is released into the bloodstream due to destruction of prostate tissue.

2. Benign Prostatic Hyperplasia (BPH)

   • Mild to moderate elevation of acid phosphatase may occur in benign enlargement of the prostate.

   • The increase is usually lower compared to malignant prostate tumors.

3. Prostatic Manipulation

   • Levels may increase temporarily after prostate massage, biopsy, catheterization, or surgical procedures involving the prostate gland.

   • This occurs due to mechanical damage to prostatic cells releasing the enzyme into circulation.

4. Bone Diseases

   • Increased acid phosphatase levels may be seen in Paget’s disease of bone, osteolytic bone lesions, and bone metastasis.

   • Osteoclasts contain acid phosphatase, and increased bone resorption leads to elevated enzyme levels.

5. Hematological Disorders

   • Certain blood diseases such as leukemia, multiple myeloma, and Gaucher’s disease may show elevated acid phosphatase levels.

   • In hairy cell leukemia, tartrate-resistant acid phosphatase (TRAP) is a characteristic laboratory marker.

6. Liver Disorders

   • Liver diseases such as cirrhosis and hepatic metastasis may also lead to moderate elevation of acid phosphatase due to tissue damage.

7. Hemolytic Conditions

   • Red blood cells contain acid phosphatase; therefore, hemolysis can increase serum enzyme levels.

   • Improper sample handling that causes hemolysis may falsely elevate results.

8. Other Conditions

   • Increased levels may also occur in hyperparathyroidism, thrombocytosis, and certain metabolic disorders.

Decreased Acid Phosphatase Levels

1. Limited Diagnostic Value

   • Decreased acid phosphatase levels generally have little clinical significance and are rarely used for diagnostic purposes.

2. Reduced Enzyme Production

   • Low levels may occur when there is decreased synthesis of the enzyme in tissues.

3. Malnutrition or Protein Deficiency

   • Severe protein-energy malnutrition may reduce enzyme production, leading to slightly decreased levels.

4. Genetic or Metabolic Disorders

   • Rare inherited metabolic conditions affecting enzyme synthesis may lead to reduced acid phosphatase activity.

5. Improper Sample Handling

   • Delayed analysis or improper storage of serum can cause enzyme degradation, resulting in falsely low values.

6. Laboratory Errors

   • Incorrect reagent preparation, improper incubation temperature, or instrument error may also produce artificially decreased results.